Clinical Characteristics and Treatment Courses of Trauma-Induced Thrombotic Microangiopathy: A Retrospective Study.

Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101606588 Publication Model: Electronic Cited Medium: Print ISSN: 2077-0383 (Print) Linking ISSN: 20770383 NLM ISO Abbreviation: J Clin Med Subsets: PubMed not MEDLINE

Original Publication: Basel, Switzerland : MDPI AG, [2012]-

Introduction: Thrombotic microangiopathy (TMA), defined by thrombocytopenia, microangiopathic hemolytic anemia, and organ injury, is not widely recognized as being trauma-related. This study aimed to describe the clinical features and outcomes of trauma-induced TMA (t-TMA) to assist in early diagnosis and management. Methods: A retrospective review was conducted on 30 trauma patients diagnosed with t-TMA between 2014 and 2019. Demographic, clinical, and laboratory data, as well as treatment methods, were analyzed. Results: Thrombocytopenia (<50,000/µL) occurred, on average, 2.9 days post-trauma, with diagnosis following 3.6 days later. Patients had a mean age of 67.6 years, and 63.3% were male. Clinical presentations included acute kidney injury (AKI) requiring renal replacement therapy (86.7%), altered mental status (53.3%), non-infectious fever (50%), and digital necrosis (43.3%). Eighteen patients were treated with therapeutic plasma exchange (TPE) alone, nine with TPE and methylprednisolone, and three with methylprednisolone alone. Remission was achieved in 96.7% of all cases. The mean TPE duration was 6.1 days, prolonged by prior platelet transfusions. The mortality rate was 26.7% (8/30), with sepsis being the most common cause of death (five patients), particularly for those treated with TPE and methylprednisolone. Conclusions: Trauma-induced TMA should be suspected in trauma patients presenting with unexplained thrombocytopenia, AKI, and elevated LDH. Early diagnosis and prompt treatment are crucial, while unnecessary platelet transfusions should be avoided. Careful infection management is critical to improving patient outcomes, particularly if patients are treated with TPE and methylprednisolone.

J Med Case Rep. 2018 Aug 9;12(1):216. (PMID: 30089509)
Thromb J. 2018 Aug 11;16:20. (PMID: 30127669)
Cureus. 2023 Oct 17;15(10):e47196. (PMID: 38021690)
Br Med J. 1952 Oct 25;2(4790):897-903. (PMID: 12978378)
Hematology Am Soc Hematol Educ Program. 2015;2015:631-6. (PMID: 26637781)
Crit Care Explor. 2023 Oct 27;5(11):e0988. (PMID: 38304709)
Surg Today. 2015 Jan;45(1):8-16. (PMID: 24374368)
Blood. 2021 Mar 11;137(10):1310-1317. (PMID: 33512445)
Crit Care. 2007;11(2):R31. (PMID: 17331245)
N Engl J Med. 2002 Aug 22;347(8):589-600. (PMID: 12192020)
N Engl J Med. 2014 Nov 6;371(19):1847-8. (PMID: 25372103)
Lancet Haematol. 2016 May;3(5):e237-45. (PMID: 27132698)
Medicine (Baltimore). 2022 Jul 22;101(29):e29315. (PMID: 35866764)
Blood. 2017 May 25;129(21):2836-2846. (PMID: 28416507)
Blood. 2015 Jun 18;125(25):3860-7. (PMID: 25784681)
Am J Emerg Med. 2016 May;34(5):939.e3-4. (PMID: 26508579)
J Thromb Haemost. 2015 Mar;13(3):380-9. (PMID: 25523333)

2021 Kyungpook National University Research Fund, 2021.

Keywords: acute renal failure; sepsis; therapeutic plasma exchange; thrombotic microangiopathy; trauma

Date Created: 20241109 Latest Revision: 20241116

20250114

PMC11547120

10.3390/jcm13216527

39518668